TECHNICAL PROGRAM - American Chemical Society Publications

BIOL/BMGT/CARB TECHNICAL PROGRAM
WEDNESDAY AFTERNOON
Section A
Boston Convention & Exhibition Center
Room 253C
Gordon Hammes ACS Biochemistry
Lectureship
Elucidations of Enzymatic Mechanisms:
From Gold to Free Radicals
J. Richard, Organizer, Presiding
1:30 264. Elucidations of enzymatic mechanisms:
From gold to free radicals.
P. A. Frey
Section A
Boston Convention & Exhibition Center
Room 253C
Hammes Lectureship Symposium
Enzymatic Reaction Mechanisms
J. Richard, Organizer, Presiding
2:40 265. Discovery and prediction of functions
in the enolase superfamily.
J. A. Gerlt
3:20 266. Unusual enzymatic transformations
during phosphonate biosynthesis.
W. van der Donk
4:00 267. Isopentenyl diphosphate isomerase:
Mechanistic studies of the type-2
enzyme. C. D. Poulter
4:40 268. Mechanism for catalysis of enzyme-catalyzed
proton transfer and decarboxylation
reactions. J. P. Richard
BMGT
Division of Business
Development and
Management
16–TECH
M. Hurrey, Program Chair
OTHER SYMPOSIA OF INTEREST:
Best Practices in Identifying,
Protecting, and Managing Your
Intellectual Property Portfolio (see
CHAL, Wed)
Recent Developments in Intellectual
Property Law: Patents, Trade
Secrets, and Trademarks (see CHAL,
Tue)
Where’s the Good Stuff? Consumer
Health Information Social
Networking, Resources and Services
(see CINF, Mon)
ACS Scholars Program Results:
Stories Highlighting 15 Successful
Years (see PRES, Mon)
Genesis of a Chemical Business (see
PROF, Mon)
Integrated Marketing for Small,
Science-Focused Businesses (see
SCHB, Wed)
SOCIAL EVENTS:
Knowledge Café and Networking
Reception, 3:20-5:00 PM: Sun
Membership Reception and Book
Signing, 5:00-7:00 PM: Mon
‡ Cooperative Cosponsorship
BUSINESS MEETING:
Open Meeting, 12:00-1:00 PM: Sun
SUNDAY AFTERNOON
Section A
Boston Convention & Exhibition Center
Room 208
Job Growth in This Economy?: Clinical
Supply Manufacture and Local Economies
of Scale Cosponsored by CPCD and NESACS
Financially supported by Vertex
Pharmaceuticals
M. Hurrey, Organizer, Presiding
12:55 Introductory Remarks
1:00 1. Pharmaceutical communities: Making
drugs, protecting jobs, and building a
local economy of scale. P. Connelly
1:20 2. LOCAL vs. CENTRAL: A conundrum
for CDMO’s. D. Mendenhall
1:40 3. Importance of local communities in
US job creation. M. Hurrey
2:00 4. Continuous manufacturing of small
molecule pharmaceuticals: The ultralean
way of manufacturing. J. M. Evans,
A. S. Myerson
2:20 5. Special challenges in the outsourced
manufacture of oncology drugs.
M. J. Kaufman
2:40 6. Navigating the critical path: Transferring
technology to a contract manufacturing
organization (CMO). E. Price
3:00 7. Development of new technologies
for contract chemistry providers: Addressing
the chemistry complexity of the
evolving NCE landscape. D. J. Coughlin
3:20 Knowledge Cafe and Reception
MONDAY MORNING
Section A
Boston Convention & Exhibition Center
Room 254A/B
Open-source Drug Discovery Cosponsored
by CPCD, MEDI, and NESACS
R. Harper, B. Munos, Organizers, Presiding
8:30 Introductory Remarks
8:35 8. Open innovation: A novel approach
to collaborative research for global good.
S. K. Brahmachari
9:05 9. New ecology of collaborative pharmaceutical
research. C. Austin
9:35 10. Producing drug innovation on a
shoestring: Innovation networks for neglected
diseases. S. Nwaka
10:05 Intermission
10:20 11. GSK’s approach to open source
malaria drug discovery. F. Gamo
10:50 12. Innovating in drug innovation:
What’s next? A. Bingham
11:20 Panel Discussion
Genesis of a Chemical Business Sponsored
by PROF, Cosponsored by BMGT, SCHB, and
YCC
Sustaining a Chemical Business with
Federal Grants & Contracts Sponsored by
SCHB, Cosponsored by BMGT, PROF, and
WCC
MONDAY AFTERNOON
Section A
Boston Convention & Exhibition Center
Room 254A/B
Open-source Drug Discovery Cosponsored
by CPCD, MEDI, and NESACS
R. Harper, B. Munos, Organizers, Presiding
1:30 Introductory Remarks
1:35 13. Compelling economics of open innovation
for drug R. B. Munos
2:05 14. OSDD: Making open innovation
work. Z. Thomas
2:35 15. Lilly’s phenotypic drug discovery
initiative. M. Pineiro-Nunez
3:05 16. Distributed drug discovery (D3):
Linking basic research and education to
find drug leads for neglected diseases.
W. Scott
3:35 17. Collaborative drug discovery: A
Platform for transforming neglected disease
R&D and beyond. S. Ekins
4:05 Panel Discussion
TUESDAY MORNING
Section A
Sheraton Boston
Republic Ballroom B
Chemistry: The Future-proof Profession
Cosponsored by CEPA, SCHB ‡ , SOCED, and
WCC
C. Duane, Organizer, Presiding
8:00 Introductory Remarks
8:10 18. Once a chemist, always a chemist?
N. R. Gray
8:40 19. From chemistry to finance to philanthropy:
An unplanned journey.
S. C. Tang
9:10 20. Love food as well as chemistry?
Combining passions with chemistry for a
successful career. C. Fisher
9:40 21. Business development: A viable career
path for chemists. B. Chaloner-Gill
10:10 22. What sustainability means to me.
M. A. Cavanaugh
10:40 23. A chemist’s tale: Research to
global environmental consulting.
J. H. Exner
11:10 24. Engineering and chemistry: Miscible,
energetic, explosive? A. Lombard
TUESDAY AFTERNOON
Section A
Sheraton Boston
Republic Ballroom B
Chemistry: The Future-proof Profession
Cosponsored by CEPA, SCHB ‡ , SOCED, and
WCC
C. Duane, Organizer, Presiding
2:00 Introductory Remarks
2:05 25. A chemical education: Gaining
common skills for uncommon opportunities!
B. Lawlor
2:35 26. A chemist ’s skills lead to success
in the non-profit sector. J. Stoner
3:05 27. Chemists without laboratory borders:
Alternative careers in research administration.
P. K. Dorhout
3:35 28. Scientific publishing: The (not so)
accidental profession. B. D. Crawford
4:05 29. With a foundation of chemistry anything
is possible! C. Martin
4:35 Panel Discussion
Women Chemists of Color Summit: Staying
at the Table Sponsored by PRES,
Cosponsored by BMGT, CMA, COMSCI, JSD,
PROF, and YCC
TUESDAY EVENING
Town Hall Forum & Poster Session
Sponsored by PROF, Cosponsored by BMGT,
SCHB, and YCC
WEDNESDAY MORNING
Section A
Boston Convention & Exhibition Center
Room 208
Open Innovation: The New Paradigm for
Competitive Advantage Cosponsored by
NESACS Financially supported by BASF
D. Daly, V. Bornemann, Organizers
A. Loaiza, Presiding
9:00 Introductory Remarks
9:05 30. Implementing open innovation:
Road warrior or road kill, it’s your choice.
G. Slowinski
9:45 31. Bringing sustainability to open innovation.
M. Mascianica
10:15 32. Manage your IP well to win the
open innovation race. R. P. Taylor
10:45 33. InnoCentive’s open innovation
rapid adoption methods and practices
(ONRAMP) program. G. Eichler
11:15 34. Open innovation for long term
projects. H. Guan
11:45 35. Identifying disruptive opportunities
in the materials marketplace: An example
from the conformal barrier coatings
market. E. M. Yokley, C. Hollinsed
WEDNESDAY AFTERNOON
Section A
Boston Convention & Exhibition Center
Room 208
Open Innovation: The New Paradigm for
Competitive Advantage Cosponsored by
NESACS Financially supported by BASF
D. Daly, V. Bornemann, Organizers
A. Loaiza, Presiding
2:00 36. Do organizations continually need
to explore, test and experiment with new
business models, in the same way they
do with new products and technologies
today? S. Kaplan
2:25 37. Open innovation and the faculty entrepreneur:
Opportunities and perils.
R. D. Rogers, D. T. Daly, G. Gurau
2:50 Panel Discussion
CARB
Division of Carbohydrate
Chemistry
T. Lowary, Program Chair
SOCIAL EVENTS:
Wolfrom-Isbell-New Investigator
Award Dinner: Mon
SUNDAY MORNING
Section A
Boston Convention & Exhibition Center
Room 251
Wolfrom-Isbell-New Investigator Award
Symposium
G. Eggleston, Organizer
T. Lowary, Organizer, Presiding
9:15 Introductory Remarks
9:20 1. Developing an enzymatic approach
to synthesize heparan sulfates. J. Liu
10:00 2. Creating and implementing breakthrough
medical technology.
R. S. Langer
10:40 3. Advances in heparin analysis and
synthesis. R. J. Linhardt
Photographing or recording
meeting sessions and/or
activities other than your own
are prohibited at all official
ACS events without written
consent from ACS.